Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2002
03/14/2002US20020032314 Synthetic peptide neutrophil cell chemotactic agents
03/14/2002US20020032312 Recombinant multispecific molecule comprising an anti-Fc receptor portion and an anti-target portion.
03/14/2002US20020032311 Interleukin-19
03/14/2002US20020032308 Oocydin and methods of use for protection of plants from Oomyocyte pathogens
03/14/2002US20020031807 Proteases from gram-positive organisms
03/14/2002US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom
03/14/2002US20020031800 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use
03/14/2002US20020031494 Nucleic acids for reducing carbohydrate epitopes
03/14/2002DE10042177A1 New acetylcholine receptor subunit, useful for identifying plant-protection and therapeutic agents, comprises segment of insect subunit inserted into vertebrate subunit
03/14/2002CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice
03/14/2002CA2422114A1 Novel human cancer/testis antigen and gene thereof
03/14/2002CA2421922A1 Proteases
03/14/2002CA2421912A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
03/14/2002CA2421783A1 Receptor in the edb fibronectin domain
03/14/2002CA2421760A1 G-csf analog compositions and methods
03/14/2002CA2421757A1 G-csf analog compositions and methods
03/14/2002CA2421714A1 Improved bioactive whey protein hydrolysate
03/14/2002CA2421274A1 Method for down-regulating ige
03/14/2002CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
03/14/2002CA2421218A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421187A1 Family member of inhibitor of apoptosis proteins
03/14/2002CA2421155A1 Osteoclast-associated receptor
03/14/2002CA2421075A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2421070A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
03/14/2002CA2421027A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002CA2419979A1 Mammalian genes; related reagents and methods
03/14/2002CA2419975A1 Enzymes having high temperature polymerase activity and methods of use thereof
03/14/2002CA2419577A1 Manganese lipoxygenase
03/14/2002CA2416858A1 High growth methanotrophic bacterial strain methylomonas 16a
03/14/2002CA2389739A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
03/13/2002EP1186661A1 Identification of the major capacitative calcium channel in antigen presenting cells and uses thereof
03/13/2002EP1186660A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombination technique
03/13/2002EP1186617A1 Novel recombinant antibody, amino acid sequences of cdrs thereof and genes encoding the same
03/13/2002EP1186616A1 Antifucoidan antibody
03/13/2002EP1186301A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/13/2002EP1185700A1 49 human secreted proteins
03/13/2002EP1185694A1 49 human secreted proteins
03/13/2002EP1185691A1 Neisseria genomic sequences and methods of their use
03/13/2002EP1185678A2 R1 protein from wheat and the use thereof for the production of modified strach
03/13/2002EP1185671A2 Rice sucrose synthase promoter
03/13/2002EP1185656A1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes
03/13/2002EP1185650A1 Head trauma induced cytoplasmatic calcium binding protein
03/13/2002EP1185648A2 Methods and compositions for inhibiting neoplastic cell growth
03/13/2002EP1185646A1 Recombinant nematode nicotinic receptor and uses
03/13/2002EP1185645A1 Adipocyte complement related protein homolog zacrp7
03/13/2002EP1185643A1 Adipocyte complement related protein homolog zacrp5
03/13/2002EP1185642A2 Compositions and methods for the treatment of tumor
03/13/2002EP1185641A1 Cytokine receptor mouse zcytor10
03/13/2002EP1185640A1 Lipocalin family protein
03/13/2002EP1185638A1 Gene and protein sequences of phage t4 gene 35
03/13/2002EP1185629A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds
03/13/2002EP1185559A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
03/13/2002EP1185558A1 Peptide having preptin functionality
03/13/2002EP1185557A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
03/13/2002EP1185555A2 Compositions isolated from skin cells and methods for their use
03/13/2002EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
03/13/2002EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
03/13/2002EP1185547A2 Gene expression modulated in gastrointestinal inflammation
03/13/2002EP1185543A1 50 human secreted proteins
03/13/2002EP1185285A1 49 human secreted proteins
03/13/2002EP1185284A1 47 human secreted proteins
03/13/2002EP1185158A1 Method for producing stress proteins from vegetable material and harvesting machine for implementing said method
03/13/2002EP0721342B1 Polypeptides of the semaphorin gene family
03/13/2002EP0698115B1 Methods and compositions relating to sterol regulatory element binding proteins
03/13/2002EP0672118B1 A novel b-lymphoma cell line and antigen
03/13/2002CN1340105A Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells
03/13/2002CN1340103A Complex-forming proteins
03/13/2002CN1340102A Polypeptide variants with raised heparin-binding capacity
03/13/2002CN1340059A Peptides
03/13/2002CN1339606A Technological process of continuously perfused culture of hybrid tumor and CHO cell to prepare antibody
03/12/2002US6355788 A polynucleotide encoding a protein that regulates tumor growth factors; diagnosis and therapy for atherosclerosis; understand gonadal pituitary hypothalamic regulation, tooth and bone formation, spermatogenesis, and differentiation
03/12/2002US6355779 An antibody member from the tumor necrosis factor receptor super family; cancer therapy, understanding immune responses
03/12/2002US6355774 Isolated p27 protein
03/12/2002US6355484 Methods and compositions for polypeptides engineering
03/12/2002US6355463 UDP-N-acetylenolpyruvylglucosamine reductase
03/12/2002US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
03/12/2002US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody
03/12/2002US6355440 Detecting cell growth factors in sample; mix target sample with preferential receptors, detect binding, bound receptor indicates presence of cell growth factor in sample
03/12/2002US6355411 Virulence-associated nucleic acid sequences and uses thereof
03/12/2002US6355254 Pathogenic Escherichia coli associated protein EspA
03/12/2002US6355253 Bactericidal antibodies
03/12/2002US6355245 Glomerulonephritis,antibodies at low dosage
03/12/2002CA2357081A1 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor
03/12/2002CA2189657C Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
03/12/2002CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease
03/12/2002CA2034741C Therapeutic antibody based fusion proteins
03/12/2002CA1341347C Androgen receptor proteins, recombinant dna molecules coding for such, and use of such compositions
03/07/2002WO2002018644A2 Mass spectrometric analysis of biopolymers
03/07/2002WO2002018586A1 Design and construction of transcription template for synthesizing cell-free protein, and dilution batch-type method of synthesizing cell-free wheat germ protein by using the same
03/07/2002WO2002018581A2 G-protein coupled receptors
03/07/2002WO2002018575A2 Genes expressed in the cell cycle
03/07/2002WO2002018570A1 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
03/07/2002WO2002018557A2 Human kinases
03/07/2002WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/07/2002WO2002018536A2 Truncated bard1 protein, and its diagnostic and therapeutic uses
03/07/2002WO2002018444A2 Erbb4 antagonists
03/07/2002WO2002018443A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins
03/07/2002WO2002018440A1 Anti-angiogenic peptides